NCT05238909View on ClinicalTrials.gov

Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

Enrolling by invitationOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Neurofibromatosis 1NF1Neurofibromatosis Type 1
Trial Locations (1)

60611

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER